Oncotelic Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Oncotelic Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.3M, a 2966% decline year-over-year.
  • Oncotelic Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$4.66M, a 62.6% increase year-over-year.
  • Oncotelic Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$7.9M, a 255% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $5.09M.
  • Oncotelic Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$9.39M, a 1.17% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$7.9M -$13M -255% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-12
2022 $5.09M +$14.5M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-12
2021 -$9.39M +$112K +1.17% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-20
2020 -$9.5M -$2.86M -43.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-15
2019 -$6.64M -$5.93M -831% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
2018 -$713K +$13.1M +94.8% Jan 1, 2018 Dec 31, 2018 10-K 2020-05-14
2017 -$13.8M -$158K -1.16% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-10
2016 -$13.7M $0 0% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-17
2015 -$13.7M -$1.01M -7.96% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 -$12.6M -$4.37M -52.8% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-25
2013 -$8.28M -$198K -2.45% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-30
2012 -$8.08M +$1.57M +16.3% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-30
2011 -$9.65M +$14.1M +59.4% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-20
2010 -$23.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.